期刊
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
卷 150, 期 1, 页码 17-21出版社
MOSBY-ELSEVIER
DOI: 10.1016/j.jaci.2022.05.008
关键词
Approved vaccines; variants of concern; SARS-CoV-2; COVID-19; preclinical vaccines; side effects; vaccine hesitancy; vaccine strategies
资金
- NIH/NIAID [1R21 AI158044-01]
This review examines the path of vaccine discovery for COVID-19 and discusses challenges and opportunities. It also covers emerging mutations within the SARS-CoV-2 spike protein and other issues that need to be addressed.
In the years since the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic began and spread across the globe, lessons have been learned about the challenges and opportunities that a pandemic brings to humankind. Researchers have produced many vaccines at unprecedented speed to protect people, but they have also been cognizant of the challenges presented by a new and unexpected infectious disease. The scope of this review is to examine the path of vaccine discovery so far and identify potential targets. Here, we provide insight into the leading vaccines and their advantages and challenges. We discuss the emerging mutations within the SARS-CoV-2 spike protein and other issues that need to be addressed to overcome coronavirus disease 2019 (COVID-19) completely. Future research is needed to develop a cheap, temperature-stable vaccine providing long-term immunity that protects the upper respiratory tract.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据